These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 9586291

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
    Suárez J, Castañeda MR, Gutiérrez CB, Rodríguez Barbosa JI, Tascón RI, Rodríguez Ferri EF.
    Med Clin (Barc); 1993 Oct 23; 101(13):484-7. PubMed ID: 8231381
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA.
    J Infect Dis; 2006 Mar 01; 193(5):655-63. PubMed ID: 16453260
    [Abstract] [Full Text] [Related]

  • 25. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H.
    J Infect Dis; 2008 Apr 01; 197(7):950-6. PubMed ID: 18419470
    [Abstract] [Full Text] [Related]

  • 26. [Immune status against measles and rubella among 4 Chilean groups of different ages].
    Valenzuela MT, Vega J, Leal I, Vicente M, Young V, Vera L, Fasce R, Ramírez E.
    Rev Med Chil; 1999 Mar 01; 127(3):359-65. PubMed ID: 10436723
    [Abstract] [Full Text] [Related]

  • 27. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS, Han HW, Go U, Chung HW.
    Vaccine; 2004 Dec 02; 23(3):290-7. PubMed ID: 15530670
    [Abstract] [Full Text] [Related]

  • 28. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G.
    Sanz-Moreno JC, Limia-Sánchez A, García-Comas L, Mosquera-Gutiérrez MM, Echevarria-Mayo JE, Castellanos-Nadal A, de Ory-Manchón F.
    Vaccine; 2005 Sep 30; 23(41):4921-5. PubMed ID: 15996797
    [Abstract] [Full Text] [Related]

  • 29. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT, Frisch K, Kershaw DB, Sedman AB, Bunchman TE.
    Adv Perit Dial; 1999 Sep 30; 15():269-72. PubMed ID: 10682116
    [Abstract] [Full Text] [Related]

  • 30. [Seroprevalence of antibodies to measles, rubella, mumps, hepatitis B viruses and all three poliovirus serotypes among children in Quindío, Colombia].
    González MM, Sarmiento L, Giraldo AM, Padilla L, Rey-Benito G, Castaño JC.
    Rev Salud Publica (Bogota); 2016 Feb 30; 18(1):95-103. PubMed ID: 28453157
    [Abstract] [Full Text] [Related]

  • 31. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
    St Sauver JL, Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.
    Hum Immunol; 2005 Jul 30; 66(7):788-98. PubMed ID: 16112026
    [Abstract] [Full Text] [Related]

  • 32. [Initial results and evaluation of igg antibody levels for measles, mumps, rubella and chickenpox viruses in young adults born in 1989].
    Sadowska-Galera M.
    Przegl Epidemiol; 2009 Jul 30; 63(3):363-7. PubMed ID: 19899592
    [Abstract] [Full Text] [Related]

  • 33. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
    Bernsen RM, van der Wouden JC.
    Pediatr Allergy Immunol; 2008 Sep 30; 19(6):544-51. PubMed ID: 18266826
    [Abstract] [Full Text] [Related]

  • 34. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
    Poethko-Müller C, Mankertz A.
    PLoS One; 2012 Sep 30; 7(8):e42867. PubMed ID: 22880124
    [Abstract] [Full Text] [Related]

  • 35. Virus-specific secretory IgA antibodies as a means of rapid diagnosis of measles and mumps infection.
    Friedman M, Hadari I, Goldstein V, Sarov I.
    Isr J Med Sci; 1983 Oct 30; 19(10):881-4. PubMed ID: 6662670
    [Abstract] [Full Text] [Related]

  • 36. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R, Vaccine Safety Datalink Team.
    Pediatrics; 2008 Mar 30; 121(3):e687-92. PubMed ID: 18310189
    [Abstract] [Full Text] [Related]

  • 37. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
    Libman MD, Behr MA, Martel N, Ward BJ.
    Clin Infect Dis; 2000 Dec 30; 31(6):1501-3. PubMed ID: 11096023
    [Abstract] [Full Text] [Related]

  • 38. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Dec 30; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 39. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR, Black S, Kuter BJ.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.